Christopher B. Ehrlich - 03 Feb 2022 Form 4 Insider Report for eFFECTOR Therapeutics, Inc.

Role
Director
Signature
/s/ Michael Byrnes, Attorney-in-Fact for Christopher B. Ehrlich
Issuer symbol
EFTR on OTC
Transactions as of
03 Feb 2022
Net transactions value
+$30,750
Form type
4
Filing time
07 Feb 2022, 08:00:13 UTC
Previous filing
31 Jan 2022
Next filing
10 Feb 2022
SEC
View on sec.gov

Quoteable Key Fact

"Christopher B. Ehrlich filed Form 4 for eFFECTOR Therapeutics, Inc. on 07 Feb 2022."

Quick Takeaways

  • This page summarizes Christopher B. Ehrlich's Form 4 filing for eFFECTOR Therapeutics, Inc..
  • 2 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 07 Feb 2022, 08:00.

What Changed

  • Previous filing in this sequence was filed on 31 Jan 2022.
  • Current net transaction value: +$30,750.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Source Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFTR Common Stock Purchase $25,750 +5,000 +100% $5.15 10,000 03 Feb 2022 Direct
transaction EFTR Common Stock Purchase $5,000 +1,000 +10% $5.00 11,000 04 Feb 2022 Direct
holding EFTR Common Stock 142,168 03 Feb 2022 By Locust Walk Partners LLC F1
holding EFTR Common Stock 1,034 03 Feb 2022 By Locust Walk Partners LLC F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares held directly by the Sponsor, of which Locust Walk Partners LLC ("LWP") is a member. LWP has allocated these shares to the reporting person.
F2 Represents shares held directly by the Sponsor, of which LWP is a member. LWP has allocated these shares to the reporting person's spouse.